Shenzhen NewDEL Biotech Co., Ltd.
-
NewDEL Biotech has reached a new drug joint development cooperation agreement with Heridas Lead.
Shenzhen NewDEL Biotech Co., Ltd. ("NewDEL Biotech"）and Ningbo Heridas Lead Biot
MORE -
NewDEL Biotech and Jingzhun Biotech have reached a joint development agreement for new drug development.
Shenzhen NewDEL Biotech Co., Ltd. ("NewDEL Biotech"）and Nanjing Jingzhun Biotech
MORE -
NewDEL Biotech and the Small Molecule Center have received implied approval from the US FDA for clinical trials of the first-class new drug ND-003 for the indication of atopic dermatitis
The clinical trial applications for ND-003, a Class I new drug jointly developed
MORE -
NewDEL Biotech has successfully completed tens of millions of RMB in Pre-A+ round financing!
Recently, Shenzhen NewDEL Biotech Co., Ltd. ("NewDEL Biotech"）announced the comp
MORE -
NewDEL Biotech Completes Tens of Millions RMB Series A Financing!
Recently,Shenzhen NewDEL Biotech Co., Ltd. ("NewDEL Biotech"）announced the compl
MORE
Shenzhen NewDEL Biotech Co., Ltd.
Contact: Mr. Lu Email：nd@newdel.com.cn
Telephone：+86-0755-28199301 Postal code： 518110
A1503 Building 1-A YESEN Intelligent Community,1301-76 Guanguang Rd.，Longhua Dist,Shenzhen,Guangdong,China
Copyright 2021-2022深圳市新樾生物科技有限公司版权所有 粤ICP备2022125782号
